About Rubicon
A marketing and strategy consultant who sits at the intersection of clinical insight and commercial reality. He has spent more than 25 years in medtech, pharma, and diagnostics — including leadership and management roles at Abbott, Medtronic, 3M, and Integer — helping teams decide which ideas are worth funding and which ones are not.
His work focuses on one thing: turning clinical promise into growth. Rob partners with C-Suite, Marketing VP's, and R&D leaders to clarify the real-world problem, pressure test the value story with KOLs, and build a business case that stands up to finance, procurement, and clinicians.

Deep expertise spanning product strategy, clinical evidence, and commercial execution across medtech and pharma.
40+
Projects Delivered
Your capital only goes to products with a validated path to market leadership. Our proven framework integrates multidimensional technical, clinical, and R&D due diligence with rigorous market modeling. We synthesize competitive intelligence and growth drivers to ensure capital is deployed only into assets with a validated path to market leadership.
20+
Markets Sized
Every investment decision backed by evidence, not assumptions. Drive confident product investment through Clinical, Research & Development, and market triangulation. We leverage expert consultations and comprehensive database analytics to distill complex evidence into an actionable roadmap – eliminating market ambiguity and securing your path to success.
100+
KOLs Engaged
Market credibility built before you spend a dollar on launch. Accelerate market adoption through clinical advocacy. We manage KOL identification, contact, contracting, payment and Sunshine Act collaboration for the execution of IDIs, surveys, field trials, and clinician panels. By synthesizing the 'VoC' into evidence-based messaging, we ensure your value proposition resonates with providers and drives uptake.
$2M
Investment Protected
Market entry strategies that sustain momentum long after launch. Turn insight into adoption at scale. We craft go-to-market strategies with playbooks, sales enablement, and messaging rooted in evidence, so your launch not only hits targets, but sustains momentum long after market entry.
25+
Years of Leadership
Resources concentrated on the assets with the highest return. Optimize resource allocation and cross-functional alignment. By defining rigorous segmentation, targeting, and positioning (STP) frameworks alongside multi-year product roadmaps, we isolate high-potential opportunities. This allows R&D, Marketing, and Sales to concentrate resources on assets with the highest potential ROI.
$30M
Revenue Forecasted
Revenue projections that hold up under board-level scrutiny. Enable executive decision-making with rigorous financial modeling. We translate market dynamics and value-based pricing into accurate revenue projections that hold up under institutional scrutiny. Our models provide the clarity needed to synchronize AOP targets with actual clinical and commercial scalability.
Business strategy meets life sciences — the training behind the thinking.
University of Minnesota · Minneapolis, MN
Master of Business Administration (MBA)
Emphases in Marketing and Healthcare
City University of New York · Brooklyn, NY
Bachelor of Science, Psychology
Pre-Med Concentration
Continuous learning at the intersection of medicine, commercialization, and AI.
Foundation & Potential of AI in Healthcare
University of Colorado
Data to Decision Path — AI Infusion in Healthcare
University of Colorado
AI Agents in Healthcare & Capstone
University of Colorado
Industry Credentials
3M Six Sigma Black Belt (DMAIC & DFSS)·Medical Industry Leadership Institute — Charter Member·Medical Alley Member
Navigate high-stakes product decisions with a partner who understands the intersection of clinical reality and commercial success.